Neurim Pharmaceuticals v Comptroller-General of Patents: ECJ 3 May 2012

(Order) Medicinal products for human use – Supplementary protection certificate – Regulation (EEC) No 1768/92 – Article 3 – Conditions for obtaining supplementary protection certificates – First authorisation to place a product on the market in the Member State for which the application is made – Successive authorisations to place a product on the market as a veterinary medicinal product and as a medicinal product for human use

Citations:

C-130/11, [2012] EUECJ C-130/11 – O

Links:

Bailii

Jurisdiction:

European

Cited by:

OrderNeurim Pharmaceuticals (1991) Ltd v Comptroller-General of Patents ECJ 19-Jul-2012
Medicinal products for human use – Supplementary protection certificate – Regulation (EC) No 469/2009 – Article 3 – Conditions for obtaining a supplementary protection certificate – Medicinal product having obtained a valid marketing authorisation – . .
Lists of cited by and citing cases may be incomplete.

Intellectual Property

Updated: 26 April 2022; Ref: scu.463204